Overview
Mohummad Siddiqui is an Urologist in Baltimore, Maryland. Dr. Siddiqui is rated as an Experienced provider by MediFind in the treatment of Malakoplakia. His top areas of expertise are Prostate Cancer, Muscle Invasive Bladder Cancer, Bladder Cancer, Vasectomy, and Nephrectomy. Dr. Siddiqui is currently accepting new patients.
His clinical research consists of co-authoring 96 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
22 S Green St, Baltimore, MD 21201
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Chesapeake Urology Associates LLC
Anup Vora is an Urologist in Baltimore, Maryland. Dr. Vora has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in the treatment of Malakoplakia. His top areas of expertise are Enlarged Prostate (BPH), Prostate Cancer, Urinary Tract Infection in Children, Prostatectomy, and Ureteroscopy. Dr. Vora is currently accepting new patients.
Inova Health Care Services
Edmond Paquette is an Urologist in Falls Church, Virginia. Dr. Paquette is rated as a Distinguished provider by MediFind in the treatment of Malakoplakia. His top areas of expertise are Muscle Invasive Bladder Cancer, Prostate Cancer, Familial Prostate Cancer, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Paquette is currently accepting new patients.
Loudoun Medical Group, PC
Jennifer Young is an Urologist in Reston, Virginia. Dr. Young is rated as a Distinguished provider by MediFind in the treatment of Malakoplakia. Her top areas of expertise are Obstructive Uropathy, Bilateral Hydronephrosis, Hydronephrosis, Prostatectomy, and Ureteroscopy. Dr. Young is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Prostate CancerDr. Siddiqui isElite. Learn about Prostate Cancer.
- Distinguished
- Bladder CancerDr. Siddiqui isDistinguished. Learn about Bladder Cancer.
- Familial Prostate CancerDr. Siddiqui isDistinguished. Learn about Familial Prostate Cancer.
- Muscle Invasive Bladder CancerDr. Siddiqui isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerDr. Siddiqui isDistinguished. Learn about Non-Muscle Invasive Bladder Cancer.
- Urothelial CancerDr. Siddiqui isDistinguished. Learn about Urothelial Cancer.
- Advanced
- UreteroceleDr. Siddiqui isAdvanced. Learn about Ureterocele.
- Experienced
- Bilateral HydronephrosisDr. Siddiqui isExperienced. Learn about Bilateral Hydronephrosis.
- Bladder ReconstructionDr. Siddiqui isExperienced. Learn about Bladder Reconstruction.
- BoilsDr. Siddiqui isExperienced. Learn about Boils.
- CarbuncleDr. Siddiqui isExperienced. Learn about Carbuncle.
- ChoriocarcinomaDr. Siddiqui isExperienced. Learn about Choriocarcinoma.
- Chromophobe Renal Cell CarcinomaDr. Siddiqui isExperienced. Learn about Chromophobe Renal Cell Carcinoma.